Publications by authors named "G Vigna"

Numerical abilities are complex cognitive skills essential for dealing with requirements of the modern world. Although the brain structures and functions underlying numerical cognition in different species have long been appreciated, genetic and molecular techniques have more recently expanded the knowledge about the mechanisms underlying numerical learning. In this review, we discuss the status of the research related to the neurobiological bases of numerical abilities.

View Article and Find Full Text PDF

Familial Hypercholesterolemia (FH) is characterized by an increase in Low-Density Lipoprotein Cholesterol (LDL-C) and by premature Cardiovascular Disease (CVD). However, it remains to be fully elucidated if FH impairs cholesterol efflux capacity (CEC), and whether CEC is related to lipoprotein subfraction distribution. This study aimed at comparing FH patients and age, sex and BMI matched controls in terms of LDL and HDL subfraction distribution as well as CEC.

View Article and Find Full Text PDF

Familial chylomicronemia syndrome (FCS) is a rare and severe genetic disorder, characterized by marked elevation of plasma triglycerides, often diagnosed in infancy. We describe the long-term follow-up (almost 60 years), the diagnostic assessment and the management of two siblings with severe hypertriglyceridemia and a history of pancreatitis who also developed cardiovascular complications later in life. We recently disclosed that the surviving index case was homozygous for a pathogenic LPL gene variant (c.

View Article and Find Full Text PDF

Numerical abilities are fundamental in our society. As a consequence, poor numerical skills might have a great impact on daily living. This study analyzes the extent to which the numerical deficit observed in young adults with Developmental Dyscalculia (DD) impacts their activities of everyday life.

View Article and Find Full Text PDF
Article Synopsis
  • Homozygous familial hypercholesterolemia (HoFH) is a rare and severe condition that is difficult to treat, often requiring both lipid-lowering medications and lipoprotein apheresis (LA) for management.
  • A study comparing two groups of HoFH patients treated with lomitapide and LA showed that lomitapide resulted in a greater reduction in LDL-C levels and a possibly lower cardiovascular event rate, despite the fact that treatment goals were not fully met for a large portion of patients in either group.
  • The findings suggest that lomitapide may offer better LDL-C control compared to LA, but further research is necessary to determine its impact on overall cardiovascular risk.
View Article and Find Full Text PDF